Korean J Obstet Gynecol.
2000 Jun;43(6):992-997.
The effect of Vitamin D(3)addition on bone mineral density in postmenopausal hormone replacement
Abstract
OBJECTIVE
To determine the effect of the addition of Vit. D3 (1,25-Dihydroxychole calciferol D3) to the conventional
postmenopausal hormone replacement therapy on bone mineral density(BMD)
DESIGN: A 2-year retrospective , randomized study Setting : Department of Obstetrics and Gynecology of Catholic
university hospital Patients : 388 postmenopausal women were recruited and divided into 5 groups according to
treatment regimen; A: conjugated estrogens only treated group(n=146), B : conjugated estrogens and progesterone
treated group(n=103), C : conjugated estrogens and Vit.D3 treated group (n=36), D : conjugated estrogens, progesterone
and Vit.D3 treated group (n=41), E : control group (n=60).
METHODS
The bone mineral density of the lumbar spines
and femoral neck were determined by dual-energy X-ray absorptiometry(DEXA) every 2 years.
STATISTICS: The difference between before and after treatment was determined by paired t-test. The comparison among
the groups were determined by one way ANOVA test and student's t-test.
RESULTS
The addition of progesterone to estrogen showed insignificant increase in the lumbar and femoral neck BMD. The addition of Vit. D3 compared with conventional
hormone replacement therapy insignificantly influened bone density in women with initially normal BMD, but definitely
increase in women with initially osteopenic and osteoporotic BMD of femoral neck rather than lumar spine(p<0.05).
CONCLUSIONS
The use of Vit. D3 combined with postmenopausal estrogen replacement effects the increase of BMD in low
bone density than normal bone density, especially femoral neck.